Viewing Study NCT05945732


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2025-12-25 @ 7:35 PM
Study NCT ID: NCT05945732
Status: RECRUITING
Last Update Posted: 2025-12-11
First Post: 2023-07-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: DESTINY Breast Respond HER2-low Europe
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module